All Publications

Journals

• Sharma A; Crook T; Thompson A; Palmieri C. (Feb 2010). SURGICAL ONCOLOGY Why biopsying metastatic breast cancer should be routine. NAT REV CLIN ONCOL. 7:71-74. DOI.
• Gojis O; Rudraraju B; Gudi M; Hogben K; Sousha S; Coombes CR; Cleator S; Palmieri C. (Feb 2010). The role of SRC-3 in human breast cancer. Nat Rev Clin Oncol. 7:83-89. DOI.
• Kenny LM; Contractor KB; Stebbing J; Ai-Nahhas A; Palmieri C; Shousha S; Coombes RC; Aboagye EO. (1 Nov 2009). Altered Tissue 3 '-Deoxy-3 '-[F-18]Fluorothymidine Pharmacokinetics in Human Breast Cancer following Capecitabine Treatment Detected by Positron Emission Tomography. CLIN CANCER RES. 15:6649-6657. DOI.
• Alifrangis C; Harcourt JP; Gojis O; Palmieri C. (12 Sep 2009). Poor reception?. LANCET. 374:948-948.
• Shousha S; Peston D; Gojis O; Palmieri C. (Sep 2009). An unusual triple-negative breast carcinoma. HISTOPATHOLOGY. 55:364-366. DOI.
• Gojis O; Rudraraju B; Alifrangis C; Krell J; Libalova P; Palmieri C. (Mar 2010). The role of steroid receptor coactivator-3 (SRC-3) in human malignant disease. Eur J Surg Oncol. 36:224-229. DOI.
• Contractor KB; Kenny LM; Stebbing J; Al-Nahhas A; Palmieri C; Sinnett D; Lewis JS; Hogben K; et al. (1 Sep 2009). [11C]choline positron emission tomography in estrogen receptor-positive breast cancer. Clin Cancer Res. 15:5503-5510. DOI.
• Cleator SJ; Ahamed E; Coombes RC; Palmieri C. (Jun 2009). A 2009 update on the treatment of patients with hormone receptor-positive breast cancer. Clin Breast Cancer. 9 Suppl 1:S6-S17. DOI.
• Francis RE; Myatt SS; Krol J; Hartman J; Peck B; McGovern UB; Wang J; Guest SK; et al. (Jul 2009). FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer. Int J Oncol. 35:57-68.
• Wang J; Jain S; Coombes CR; Palmieri C. (May 2009). Fulvestrant in Advanced Breast Cancer Following Tamoxifen and Aromatase Inhibition: A Single Center Experience. BREAST J. 15:247-253. DOI.
• Barrett-Lee PJ; Dixon JM; Farrell C; Jones A; Leonard R; Murray N; Palmieri C; Plummer CJ; et al. (May 2009). Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. ANN ONCOL. 20:816-827. DOI.
• Hiley C; Tutt A; Torres M; Palmieri C. (30 Dec 2008). Adjuvant radiotherapy for breast cancer. BRIT MED J. 337. DOI.
• Palmieri C; Gojis O; Rudraraju B; Cleator S. (10 Dec 2008). Does ER-beta cx Really Have No Clinical Importance in Tamoxifen-Treated Breast Cancer Patients?. J CLIN ONCOL. 26:5824-5824. DOI.
• Abbott R; Palmieri C. (Dec 2008). Angiosarcoma of the breast following surgery and radiotherapy for breast cancer. NAT CLIN PRACT ONCOL. 5:727-736. DOI.
• Cleator SJ; Palmieri C; Coombes CR. (2008). The Ethnic Profile of Triple-Negative Breast Cancer. ONKOLOGIE. 31:580-582. DOI.
• Stavridi F; Palmieri C. (Dec 2008). Efficacy and toxicity of nonpegylated liposomal doxorubicin in breast cancer. Expert Rev Anticancer Ther. 8:1859-1869. DOI.
• Slade MJ; Payne R; Riethdorf S; Ward B; Zaidi SA; Stebbing J; Palmieri C; Sinnett HD; et al. (13 Jan 2009). Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment. Br J Cancer. 100:160-166. DOI.
• Neelakantan P; McLean SR; Kenny S; Nathan M; Panchal L; Sandhu G; Coombes CR; Palmieri C. (Jun 2008). Breast cancer metastasizing to the tongue. Can J Surg. 51:E63-E64.
• Palmieri C; Coombes RC; Kim SB; Cleator S. (19 Jul 2008). Ethnicity and breast cancer research. Lancet. 372:188-189. DOI.
• Kenny LM; Coombes RC; Oulie I; Contractor KB; Miller M; Spinks TJ; McParland B; Cohen PS; et al. (Jun 2008). Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand F-18-AH111585 in breast cancer patients. J NUCL MED. 49:879-886. DOI.
• McLean SR; Shousha S; Francis N; Lim A; Eccles S; Nathan M; Brock CS; Palmieri C. (Dec 2007). Metastatic ductal eccrine adenocarcinoma masquerading as an invasive ductal carcinoma of the male breast. J CUTAN PATHOL. 34:934-938. DOI.
• Palmieri C; Dhillon T; Fisher RA; Young AM; Short D; Mitchell H; Aghajanian C; Savage PM; et al. (Jul 2007). Management and outcome of healthy women with a persistently elevated beta-hCG. GYNECOL ONCOL. 106:35-43. DOI.
• Heller W; Mazhar D; Ward R; Sinnett HD; Lowdell C; Phillips R; Shousha S; Fayaz A; et al. (Jan 2007). Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer. Oncol Rep. 17:253-259.
• Palmieri C; MacGregor T; Girgis S; Vigushin D. (Dec 2006). Serum 25-hydroxyvitamin D levels in early and advanced breast cancer. J Clin Pathol. 59:1334-1336. DOI.
• Dhillon T; Palmieri C; Sebire NJ; Lindsay I; Newlands ES; Schmid P; Savage PM; Frank J; et al. (Nov 2006). Value of whole body (18)FDG-PET to identify the active site of gestational trophoblastic neoplasia. JOURNAL OF REPRODUCTIVE MEDICINE. 51:879-887.
• Palmieri C; Dhillon T; Thirlwell C; Newsom-Davis T; Young AM; Nelson M; Gazzard BG; Bower M. (Jul 2006). Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy. HIV Med. 7:291-293. DOI.
• Stebbing J; Mazhar D; Lewis R; Palmieri C; Hatzimichael E; Nelson M; Gazzard B; Bower M. (Mar 2006). The presentation and survival of patients with non-cutaneous AIDS-associated Kaposi's sarcoma. Ann Oncol. 17:503-506. DOI.
• Bower M; Palmieri C; Dhillon T. (Feb 2006). AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis. 19:14-19.
• Palmieri C; Fisher RA; Sebire NJ; Lindsay I; Smith JR; McCluggage WG; Savage P; Seckl MJ. (20 Aug 2005). Placental site trophoblastic tumour arising from a partial hydatidiform mole. Lancet. 366:688. DOI.
• Fraser SP; Diss JK; Chioni AM; Mycielska ME; Pan H; Yamaci RF; Pani F; Siwy Z; et al. (1 Aug 2005). Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res. 11:5381-5389. DOI.
• Palmieri C; Brock C; Newlands ES. (Jun 2005). Maintenance of fertility following treatment with temozolomide for a high grade astrocytoma. J NEURO-ONCOL. 73:185-185. DOI.
• Levene AP; Singh G; Palmieri C. (Apr 2005). Therapeutic monoclonal antibodies in oncology. J ROY SOC MED. 98:146-152.
• Palmieri C; Vigushin D. (24 Mar 2005). Palifermin and chemotherapy-induced oral mucositis. NEW ENGL J MED. 352:1264-1265.
• Palmieri C; Fisher RA; Sebire NJ; Smith JR; Newlands ES. (Jan 2005). Placental-site trophoblastic tumour: an unusual presentation with bilateral ovarian involvement. Lancet Oncol. 6:59-61. DOI.
• Palmieri C; Coombes RC; Vigushin DM. (2005). Targeted histone deacetylase inhibition for cancer prevention and therapy. Prog Drug Res. 63:147-181.
• Palmieri C; Saji S; Sakaguchi H; Cheng G; Sunters A; O'Hare MJ; Warner M; Gustafsson JA; et al. (Aug 2004). The expression of oestrogen receptor (ER)-beta and its variants, but not ERalpha, in adult human mammary fibroblasts. J Mol Endocrinol. 33:35-50.
• Palmieri C; Dhillon T; Coombes C; Vigushin D. (12 Jun 2004). Hypocalcaemia after intravenous bisphosphonate - Adjuvant bisphosphonate is not currently accepted practice. BRIT MED J. 328:1439-1439.
• Neary NM; Small CJ; Wren AM; Lee JL; Druce MR; Palmieri C; Frost GS; Ghatei MA; et al. (Jun 2004). Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 89:2832-2836. DOI.
• Palmieri C; Vigushin D; Coombes RC. (22 May 2004). Stem-cell therapy for myocardial diseases. LANCET. 363:1734-1735.
• Palmieri C; Lam EWF; Vigushin D; Coombes RC. (1 May 2004). Value of SERMs in postmenopausal women. LANCET. 363:1477-1478.
• Palmieri C; Lam EW; Mansi J; MacDonald C; Shousha S; Madden P; Omoto Y; Sunters A; et al. (1 Apr 2004). The expression of ER beta cx in human breast cancer and the relationship to endocrine therapy and survival. Clin Cancer Res. 10:2421-2428.
• Palmieri C; Vigushin DM; Peters TJ. (Mar 2004). Managing malignant disease in patients with porphyria. QJM. 97:115-126.
• Palmieri C; Barron N; Vigushin DM. (1 Mar 2004). The vincotube system: A design solution to prevent the accidental administration of intrathecal Vinca alkaloids. J CLIN ONCOL. 22:965-965.
• Palmieri C; Wanaski S; Panse J; Medeiros B. (Jan 2004). The future of clinical cancer research: who's teaching the next generation? The Flims-Vail model. EUR J CANCER. 40:173-175. DOI.
• Palmieri C; Gillmore R; Menzies-Gow A; Fishpool S; Robinson D; Shaw R; Coombes RC. (Oct 2003). Resolution of late-onset asthma following high-dose chemotherapy. Bone Marrow Transplant. 32:847-848. DOI.
• Palmieri C; Roberts-Clark D; Assadi-Sabet A; Coope RC; O'Hare M; Sunters A; Hanby A; Slade MJ; et al. (Apr 2003). Fibroblast growth factor 7, secreted by breast fibroblasts, is an interleukin-1beta-induced paracrine growth factor for human breast cells. J Endocrinol. 177:65-81.
• Palmieri C; Vigushin D. (13 Jul 2002). Gene-expression profiling and identification of patients at high risk of breast cancer. LANCET. 360:173-173.
• Palmieri C; Cheng GJ; Saji S; Zelada-Hedman M; Wärri A; Weihua Z; Van Noorden S; Wahlstrom T; et al. (Mar 2002). Estrogen receptor beta in breast cancer. Endocr Relat Cancer. 9:1-13.
• Jensen EV; Cheng GJ; Palmieri C; Saji S; Makela S; Van Noorden S; Wahlstrom T; Warner M; et al. (18 Dec 2001). Estrogen receptors and proliferation markers in primary and recurrent breast cancer. P NATL ACAD SCI USA. 98:15197-15202.
• Palmieri C; Powles T; Vigushin D. (27 Sep 2001). Trastuzumab and breast cancer. NEW ENGL J MED. 345:996-997.
• Palmieri C; Saji S; Gustafsson JA; Coombes RC. (9 Sep 2000). False negatives in oestrogen-receptor assay. LANCET. 356:944-944.
• Palmieri C; Fishpool S. (2 Sep 2000). Breast cancer screening - Screening has to be combined with good surgical and oncological services. BRIT MED J. 321:567-568.
• Palmieri C. (Sep 2000). Prognostic significance of oestrogen receptor beta in breast cancer. BRIT J SURG. 87:1248-1249.
• Palmieri C; Fishpool S; Coombes RC. (5 Aug 2000). Tumour markers in malignancies - Two isoforms of oestrogen receptor are now known to exist. BRIT MED J. 321:379-380.
• Udom DI; Vigushin DM; Linardou H; Graham H; Palmieri C; Coombes RC. (Jan 2000). Two weekly vinorelbine: administration in patients who have received at least two prior chemotherapy regimes for advanced breast cancer. Eur J Cancer. 36:177-182.
• Palmieri C; Linardou H. (21 Aug 1999). Breast cancer in women with palpable breast cysts. LANCET. 354:677-677.
• Palmieri C. (5 Jun 1999). Trial of prophylactic mastectomy is needed. BRIT MED J. 318:1556-1557.

Conferences

• Kenny LM; Contractor K; Stebbing J; Al-Nahhas A; Palmieri C; Shousha S; Aboagye EO; Coombes RC. Changes in [F-18]Fluorothymidine Pharmacokinetics Following Capecitabine Treatment in Human Breast Cancer Detected by Positron Emission Tomography. 32nd Annual San Antonio Breast Cancer Symposium, 9 Dec 2009 - 13 Dec 2009. 69:765S-765S. AMER ASSOC CANCER RESEARCH (15 Dec 2009).
• Mclean SR; Shousha S; Francis N; Lim A; Eccles S; Brock CS; Palmieri C. Metastatic ductal eccrine adenocarcinoma masquerading as an invasive ductal carcinoma of the male breast. 8th Conference of the Western Student Medical Research Forum, 2 Feb 2007. 55:S93-S93. B C DECKER INC (Jan 2007).
• Abbott R; Vigushin DM; Coombes RC; Palmieri C. Angiosarcoma of the breast following breast preserving surgery and radiotherapy: A review of the literature. 29th Annual San Antonio Breast Cancer Symposium. 100:S235-S235. (Jan 2006).
• Seckl M; Dhillon T; Young AM; Mitchell H; Newlands ES; Hancock B; Palmieri C. Management and outcome of healthy women with a persistently elevated serum beta-hCG. 41st Annual Meeting of the American-Society-of-Clinical-Oncology, 13 May 2005 - 17 May 2005. 23:475S-475S. AMER SOC CLINICAL ONCOLOGY (1 Jun 2005).
• Palmieri C; Macgregor T; Girgis S; Vigushin DM. Serum 25 hydroxyvitamin D levels in early and advanced breast cancer. 41st Annual Meeting of the American-Society-of-Clinical-Oncology, 13 May 2005 - 17 May 2005. 23:36S-36S. AMER SOC CLINICAL ONCOLOGY (1 Jun 2005).
• Dhillon T; Palmieri C; Newlands E; Franks J; Seckl M. Whole body positron emission tomography (PET) for the detection of residual disease in gestational trophoblastic tumors (GTTs). 41st Annual Meeting of the American-Society-of-Clinical-Oncology, 13 May 2005 - 17 May 2005. 23:481S-481S. AMER SOC CLINICAL ONCOLOGY (1 Jun 2005).
• Palmieri C; Lam E; Mansi J; Madden P; Warner M; Gustafsson JA; Coombes RC. The expression of ER beta cx in human breast cancer and the relationship to response to endocrine therapy and survival. 26th Annual San Antonio Breast Cancer Symposium, 3 Dec 2003 - 6 Dec 2003. 82:S62-S62. KLUWER ACADEMIC PUBL (Jan 2003).
• Gustafsson JA; Cheng G; Jensen E; Palmieri C; Coombes C; Warner M. The latest on ER-beta in breast cancer. 3rd Biennial International Meeting of the Flemish-Gynaecological-Oncology-Group. 38:S81-S81. (Nov 2002).